Aurobindo Pharma

company 1 Deal 1 Partner

Hyderabad-based pharmaceutical company with a global presence in 150+ markets, including the US and Europe. Operates 29 manufacturing facilities worldwide, producing over 50 billion formulations units and 19,000+ MT APIs annually. Focuses on making medicines affordable and accessible, with a strong R&D pipeline for biosimilars in oncology and immunology.

Get alerts when new deals involving Aurobindo Pharma are announced — free, no spam.

Pharmaceutical Company

Strategic Overview

The company's primary focus is on pharmaceuticals, not infrastructure. While it has a global presence and manufacturing facilities, these are related to its core business and not indicative of infrastructure investment preferences.
The mention of a 'flagship Penicillin-G Facility at Kakinada, Andhra Pradesh' inaugurated by the Prime Minister suggests a significant manufacturing operation, but this is within the pharmaceutical industry.

Deal History (1)

Aurobindo Pharma to acquire 26% stake in Swarnaakshu Solar Power for captive renewable energy project

Buyer Solar India Apr 6, 2026

Investment Focus

Technologies

Solar1

Geography

India1

Detailed Analysis

Sectors

Utilities

Geographies

USEuropeIndia

Subsidiaries

Aurobindo Pharma USA Inc (APUSA)Aurolife Pharma LLCAuroHealth LLCAcrotech Biopharma IncVespyr Brands, INC.Aurologistics LLCAuropackaging LLC

Access the complete profile — deal history, track record, and investment analysis.

View Full Profile